HEADER HYDROLASE 26-SEP-94 1INW TITLE A SIALIC ACID DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT STRAINS OF TITLE 2 INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT EFFICIENCIES CAVEAT 1INW MAN B 3 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INFLUENZA A SUBTYPE N2 NEURAMINIDASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.18; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 11320; SOURCE 4 CELL_LINE: 293; SOURCE 5 EXPRESSION_SYSTEM_STRAIN: 293 KEYWDS HYDROLASE, O-GLYCOSYL, NEURAMINIDASE, SIALIDASE EXPDTA X-RAY DIFFRACTION AUTHOR C.L.WHITE,M.N.JANAKIRAMAN,W.G.LAVER,C.PHILIPPON,A.VASELLA,G.M.AIR, AUTHOR 2 M.LUO REVDAT 6 30-OCT-24 1INW 1 REMARK HETSYN REVDAT 5 29-JUL-20 1INW 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HETNAM LINK SITE ATOM REVDAT 4 13-JUL-11 1INW 1 VERSN REVDAT 3 24-FEB-09 1INW 1 VERSN REVDAT 2 01-APR-03 1INW 1 JRNL REVDAT 1 07-FEB-95 1INW 0 JRNL AUTH C.L.WHITE,M.N.JANAKIRAMAN,W.G.LAVER,C.PHILIPPON,A.VASELLA, JRNL AUTH 2 G.M.AIR,M.LUO JRNL TITL A SIALIC ACID-DERIVED PHOSPHONATE ANALOG INHIBITS DIFFERENT JRNL TITL 2 STRAINS OF INFLUENZA VIRUS NEURAMINIDASE WITH DIFFERENT JRNL TITL 3 EFFICIENCIES. JRNL REF J.MOL.BIOL. V. 245 623 1995 JRNL REFN ISSN 0022-2836 JRNL PMID 7844831 JRNL DOI 10.1006/JMBI.1994.0051 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.N.JANAKIRAMAN,C.L.WHITE,W.G.LAVER,G.M.AIR,M.LUO REMARK 1 TITL STRUCTURE OF INFLUENZA VIRUS NEURAMINIDASE REMARK 1 TITL 2 B(SLASH)LEE(SLASH)40 COMPLEXED WITH SIALIC ACID AND A REMARK 1 TITL 3 DEHYDRO ANALOG AT 1.8 ANGSTROMS RESOLUTION: IMPLICATIONS FOR REMARK 1 TITL 4 THE CATALYTIC MECHANISM REMARK 1 REF BIOCHEMISTRY V. 33 8172 1994 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.N.VARGHESE,P.M.COLMAN REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF THE INFLUENZA VIRUS REMARK 1 TITL 2 A(SLASH)TOKYO(SLASH)3(SLASH)67 AT 2.2 ANGSTROMS RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 221 473 1991 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH W.R.LIP,J.N.VARGHESE,A.T.BAKER,A.VAN DANELAAR,W.G.LAVER, REMARK 1 AUTH 2 R.G.WEBSTER,P.M.COLMAN REMARK 1 TITL REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS REMARK 1 TITL 2 NEURAMINIDASE AND ESCAPE MUTANTS REMARK 1 REF J.MOL.BIOL. V. 221 487 1991 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH K.WALLIMAN,A.VASELLA REMARK 1 TITL PHOSPHONIC-ACID ANALOGS OF THE N-ACETYL-2-DEOXYNEURAMINIC REMARK 1 TITL 2 ACIDS: SYNTHESIS AND INHIBITION OF VIBRIO CHOLEAE SIALIDASE REMARK 1 REF HELV.CHIM.ACTA V. 73 1359 1990 REMARK 1 REFN ISSN 0018-019X REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 30368 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3022 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 125 REMARK 3 SOLVENT ATOMS : 86 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 BOND ANGLES (DEGREES) : 2.050 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.13 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.640 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1INW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000174218. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37401 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 75.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NATIVE CRYSTALS SOAKED IN 10MM APANA REMARK 280 SOLUTION, PH 7.2. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.93500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.93500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 61.04000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 70.83500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 61.04000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 70.83500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.93500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 61.04000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 70.83500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.93500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 61.04000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 70.83500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 450 REMARK 450 SOURCE REMARK 450 APANA REMARK 450 SEE WALLIMAN & VASELLA (1990) FOR SYNTHESIS REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD22 ASN A 142 H HIS A 144 1.29 REMARK 500 HE22 GLN A 226 H VAL A 240 1.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 100 -38.66 -134.40 REMARK 500 PRO A 126 25.95 -78.45 REMARK 500 VAL A 127 -42.63 -138.53 REMARK 500 SER A 181 135.66 -173.32 REMARK 500 ASN A 200 40.85 -154.45 REMARK 500 SER A 219 22.16 -146.44 REMARK 500 GLN A 220 31.84 35.50 REMARK 500 ILE A 222 85.35 52.35 REMARK 500 SER A 247 69.01 -113.53 REMARK 500 HIS A 264 149.11 179.83 REMARK 500 GLU A 277 62.08 36.49 REMARK 500 ARG A 283 66.64 -155.96 REMARK 500 TYR A 284 127.98 -33.80 REMARK 500 CYS A 291 -158.70 -107.18 REMARK 500 TRP A 295 -83.36 -108.49 REMARK 500 SER A 319 134.93 -38.31 REMARK 500 VAL A 322 126.12 73.67 REMARK 500 ASP A 329 128.42 155.80 REMARK 500 SER A 332 47.97 -103.10 REMARK 500 CYS A 337 -16.98 80.81 REMARK 500 ASN A 342 13.18 59.35 REMARK 500 GLN A 347 -177.02 76.28 REMARK 500 VAL A 349 140.69 -171.14 REMARK 500 ALA A 353 161.96 171.72 REMARK 500 ASN A 387 11.71 57.09 REMARK 500 SER A 404 -143.26 -130.05 REMARK 500 TYR A 406 170.75 -56.71 REMARK 500 LYS A 431 -93.84 119.69 REMARK 500 SER A 457 133.87 -170.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 423 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE CALCIUM RESIDUE, CA 470, STABILIZES A LOOP NEAR THE REMARK 600 NEURAMINIDASE ACTIVE SITE. REMARK 600 REMARK 600 THE AXIAL PHOSPHONATE INHIBITOR IS RESIDUE AXP 500. REMARK 600 AXP IS AN AXIAL PHOSPHONATE ANALOG OF O-SIALIC ACID. REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 581 REMARK 615 HOH A 582 REMARK 615 HOH A 583 REMARK 615 HOH A 584 REMARK 615 HOH A 585 REMARK 615 HOH A 586 REMARK 615 HOH A 587 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 501 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 293 O REMARK 620 2 GLY A 297 O 84.9 REMARK 620 3 ASP A 324 OD2 79.4 81.8 REMARK 620 4 GLY A 345 O 102.1 88.2 169.8 REMARK 620 5 GLN A 347 O 92.5 175.6 101.2 88.9 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SUBSTRATE (SIALIC ACID) BINDING RESIDUES IN REMARK 800 CATALYTIC SITE DBREF 1INW A 82 469 UNP P06820 NRAM_IATOK 82 469 SEQADV 1INW ASP A 339 UNP P06820 ASN 339 CONFLICT SEQRES 1 A 388 VAL GLU TYR ARG ASN TRP SER LYS PRO GLN CYS GLN ILE SEQRES 2 A 388 THR GLY PHE ALA PRO PHE SER LYS ASP ASN SER ILE ARG SEQRES 3 A 388 LEU SER ALA GLY GLY ASP ILE TRP VAL THR ARG GLU PRO SEQRES 4 A 388 TYR VAL SER CYS ASP PRO VAL LYS CYS TYR GLN PHE ALA SEQRES 5 A 388 LEU GLY GLN GLY THR THR LEU ASP ASN LYS HIS SER ASN SEQRES 6 A 388 ASP THR VAL HIS ASP ARG ILE PRO HIS ARG THR LEU LEU SEQRES 7 A 388 MET ASN GLU LEU GLY VAL PRO PHE HIS LEU GLY THR ARG SEQRES 8 A 388 GLN VAL CYS ILE ALA TRP SER SER SER SER CYS HIS ASP SEQRES 9 A 388 GLY LYS ALA TRP LEU HIS VAL CYS ILE THR GLY ASP ASP SEQRES 10 A 388 LYS ASN ALA THR ALA SER PHE ILE TYR ASP GLY ARG LEU SEQRES 11 A 388 VAL ASP SER ILE GLY SER TRP SER GLN ASN ILE LEU ARG SEQRES 12 A 388 THR GLN GLU SER GLU CYS VAL CYS ILE ASN GLY THR CYS SEQRES 13 A 388 THR VAL VAL MET THR ASP GLY SER ALA SER GLY ARG ALA SEQRES 14 A 388 ASP THR ARG ILE LEU PHE ILE GLU GLU GLY LYS ILE VAL SEQRES 15 A 388 HIS ILE SER PRO LEU ALA GLY SER ALA GLN HIS VAL GLU SEQRES 16 A 388 GLU CYS SER CYS TYR PRO ARG TYR PRO GLY VAL ARG CYS SEQRES 17 A 388 ILE CYS ARG ASP ASN TRP LYS GLY SER ASN ARG PRO VAL SEQRES 18 A 388 VAL ASP ILE ASN MET GLU ASP TYR SER ILE ASP SER SER SEQRES 19 A 388 TYR VAL CYS SER GLY LEU VAL GLY ASP THR PRO ARG ASN SEQRES 20 A 388 ASP ASP ARG SER SER ASN SER ASN CYS ARG ASP PRO ASN SEQRES 21 A 388 ASN GLU ARG GLY THR GLN GLY VAL LYS GLY TRP ALA PHE SEQRES 22 A 388 ASP ASN GLY ASN ASP LEU TRP MET GLY ARG THR ILE SER SEQRES 23 A 388 LYS ASP LEU ARG SER GLY TYR GLU THR PHE LYS VAL ILE SEQRES 24 A 388 GLY GLY TRP SER THR PRO ASN SER LYS SER GLN ILE ASN SEQRES 25 A 388 ARG GLN VAL ILE VAL ASP SER ASP ASN ARG SER GLY TYR SEQRES 26 A 388 SER GLY ILE PHE SER VAL GLU GLY LYS SER CYS ILE ASN SEQRES 27 A 388 ARG CYS PHE TYR VAL GLU LEU ILE ARG GLY ARG LYS GLN SEQRES 28 A 388 GLU THR ARG VAL TRP TRP THR SER ASN SER ILE VAL VAL SEQRES 29 A 388 PHE CYS GLY THR SER GLY THR TYR GLY THR GLY SER TRP SEQRES 30 A 388 PRO ASP GLY ALA ASN ILE ASN PHE MET PRO ILE MODRES 1INW ASN A 86 ASN GLYCOSYLATION SITE MODRES 1INW ASN A 146 ASN GLYCOSYLATION SITE MODRES 1INW ASN A 200 ASN GLYCOSYLATION SITE MODRES 1INW ASN A 234 ASN GLYCOSYLATION SITE HET NAG B 1 27 HET NAG B 2 27 HET MAN B 3 20 HET MAN B 4 22 HET MAN B 5 22 HET NAG A 470A 28 HET NAG A 471A 28 HET NAG A 477A 28 HET AXP A 500 40 HET CA A 501 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM AXP (1S)-4-ACETAMIDO-1,5-ANHYDRO-2,4-DIDEOXY-1-PHOSPHONO-D- HETNAM 2 AXP GLYCERO-D-GALACTO-OCTITOL HETNAM CA CALCIUM ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN AXP 4-ACETAMIDO-2,4-DIDEXOY-D-GLYCERO-BETA-D-GALACTO- HETSYN 2 AXP OCTOPYRANOSYLPHOSPHONIC ACID (AN AXIAL PHOSPHONATE) FORMUL 2 NAG 5(C8 H15 N O6) FORMUL 2 MAN 3(C6 H12 O6) FORMUL 6 AXP C10 H20 N O9 P FORMUL 7 CA CA 2+ FORMUL 8 HOH *86(H2 O) HELIX 1 1 ASN A 104 SER A 109 1 6 HELIX 2 2 ALA A 110 GLY A 112 5 3 HELIX 3 3 ASN A 142 ASN A 146 5 5 HELIX 4 4 ASP A 197 ASN A 200 5 4 SHEET 1 A 4 GLY A 96 LYS A 102 0 SHEET 2 A 4 THR A 439 THR A 449 -1 N VAL A 445 O SER A 101 SHEET 3 A 4 ILE A 418 GLY A 429 -1 O ARG A 420 N GLY A 448 SHEET 4 A 4 SER A 407 GLU A 413 -1 N GLY A 408 O TYR A 423 SHEET 1 B 4 TRP A 115 CYS A 124 0 SHEET 2 B 4 CYS A 129 THR A 139 -1 N TYR A 130 O SER A 123 SHEET 3 B 4 THR A 157 GLU A 162 -1 O THR A 157 N GLY A 135 SHEET 4 B 4 ARG A 172 ILE A 176 -1 O ARG A 172 N MET A 160 SHEET 1 C 4 SER A 179 HIS A 184 0 SHEET 2 C 4 TRP A 189 THR A 195 -1 N LEU A 190 O CYS A 183 SHEET 3 C 4 THR A 202 TYR A 207 -1 N THR A 202 O THR A 195 SHEET 4 C 4 ARG A 210 GLY A 216 -1 O ARG A 210 N TYR A 207 SHEET 1 D 4 LYS A 261 PRO A 267 0 SHEET 2 D 4 ALA A 250 GLU A 258 -1 N ILE A 254 O SER A 266 SHEET 3 D 4 THR A 236 GLY A 244 -1 N CYS A 237 O ILE A 257 SHEET 4 D 4 ARG A 224 THR A 225 -1 N ARG A 224 O THR A 242 SHEET 1 E 4 LYS A 261 PRO A 267 0 SHEET 2 E 4 ALA A 250 GLU A 258 -1 N ILE A 254 O SER A 266 SHEET 3 E 4 THR A 236 GLY A 244 -1 N CYS A 237 O ILE A 257 SHEET 4 E 4 VAL A 231 ILE A 233 -1 O VAL A 231 N THR A 238 SHEET 1 F 4 GLU A 276 ARG A 283 0 SHEET 2 F 4 GLY A 286 ARG A 292 -1 N GLY A 286 O ARG A 283 SHEET 3 F 4 PRO A 301 ASN A 306 -1 O PRO A 301 N CYS A 291 SHEET 4 F 4 ILE A 312 TYR A 316 -1 O ASP A 313 N ASP A 304 SHEET 1 G 4 ALA A 353 ASN A 356 0 SHEET 2 G 4 ASP A 359 ARG A 364 -1 N ASP A 359 O ASN A 356 SHEET 3 G 4 SER A 372 ILE A 380 -1 N GLU A 375 O ARG A 364 SHEET 4 G 4 SER A 390 ARG A 403 -1 O SER A 390 N ILE A 380 SSBOND 1 CYS A 92 CYS A 417 1555 1555 2.03 SSBOND 2 CYS A 124 CYS A 129 1555 1555 2.01 SSBOND 3 CYS A 175 CYS A 193 1555 1555 2.02 SSBOND 4 CYS A 183 CYS A 230 1555 1555 2.02 SSBOND 5 CYS A 232 CYS A 237 1555 1555 2.03 SSBOND 6 CYS A 278 CYS A 291 1555 1555 2.03 SSBOND 7 CYS A 280 CYS A 289 1555 1555 2.02 SSBOND 8 CYS A 318 CYS A 337 1555 1555 2.02 SSBOND 9 CYS A 421 CYS A 447 1555 1555 2.03 LINK ND2 ASN A 86 C1 NAG A 470A 1555 1555 1.46 LINK ND2 ASN A 146 C1 NAG A 471A 1555 1555 1.47 LINK ND2 ASN A 200 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 234 C1 NAG A 477A 1555 1555 1.47 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.41 LINK O4 NAG B 2 C1 MAN B 3 1555 1555 1.42 LINK O3 MAN B 3 C1 MAN B 4 1555 1555 1.41 LINK O6 MAN B 3 C1 MAN B 5 1555 1555 1.45 LINK O ASP A 293 CA CA A 501 1555 1555 2.34 LINK O GLY A 297 CA CA A 501 1555 1555 2.40 LINK OD2 ASP A 324 CA CA A 501 1555 1555 2.87 LINK O GLY A 345 CA CA A 501 1555 1555 2.30 LINK O GLN A 347 CA CA A 501 1555 1555 2.25 CISPEP 1 TYR A 284 PRO A 285 0 0.24 CISPEP 2 THR A 325 PRO A 326 0 -0.50 SITE 1 CAT 11 VAL A 116 THR A 117 VAL A 149 HIS A 150 SITE 2 CAT 11 ALA A 177 ASN A 221 LEU A 223 VAL A 275 SITE 3 CAT 11 ARG A 292 TYR A 374 ILE A 409 CRYST1 122.080 141.670 141.870 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008191 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007059 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007049 0.00000